Background: Percutaneous Coronary Intervention (PCI) of bifurcation disease remains a challenge in terms of procedural success rate as well as long term Major Adverse Cardiac Events (MACE), Target Lesion Revascularization (TLR), restenosis, and Stent Thrombosis (ST). Bifurcation interventions, when compared with nonbifurcation interventions, have a lower rate of procedural success and a higher rate of restenosis.